VTCN1 Produits
(V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories VTCN1 en vedette
VTCN1 Anticorps
High quality antibodies with extensive validation data.
VTCN1 Kits ELISA
Reliable ELISA kits for a wide range of species.
VTCN1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
VTCN1 recommandé Anticorps
- (1)
- (7)
- (6)
- (5)
VTCN1 recommandé Kits ELISA
- (1)
- (5)
- (1)
- (1)
VTCN1 recommandé Protéines
- (4)
- (4)
- (4)
Dernières publications sur nos produits VTCN1
: "The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma." dans: Journal of cancer research and clinical oncology, (2022) (PubMed).: "Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus." dans: Iranian journal of immunology : IJI, Vol. 16, Issue 1, pp. 43-52, (2019) (PubMed).
: "VISTA is an acidic pH-selective ligand for PSGL-1. ..." dans: Nature, Vol. 574, Issue 7779, pp. 565-570, (2019) (PubMed).
: "Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 23, Issue 12, pp. 2934-2941, (2018) (PubMed).
: "Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer." dans: Oncology letters, Vol. 11, Issue 4, pp. 2815-2819, (2016) (PubMed).
: "Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 196, Issue 4, pp. 1495-506, (2016) (PubMed).
: "Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients." dans: Oncotarget, Vol. 7, Issue 47, pp. 77237-77243, (2016) (PubMed).
: "Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance." dans: International journal of clinical oncology, Vol. 20, Issue 2, pp. 273-81, (2015) (PubMed).
: "B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity." dans: Cancer immunology research, Vol. 3, Issue 2, pp. 184-95, (2015) (PubMed).
: "Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis." dans: Tumour biology, (2014) (PubMed).
Synonymes et noms alternatifs relatifs à VTCN1
V set domain containing T cell activation inhibitor 1 L homeolog (vtcn1.L), V-set domain containing T cell activation inhibitor 1 (VTCN1), V-set domain containing T-cell activation inhibitor 1 (VTCN1), V set domain containing T cell activation inhibitor 1 (vtcn1), V-set domain containing T cell activation inhibitor 1 (Vtcn1), B7-H4, B7h.5, B7h4, B7H4, B7s1, B7S1, B7x, B7X, BC032925, PRO1291, RGD1311204, VCTN1Protein level used designations for VTCN1
- V-set domain-containing T-cell activation inhibitor 1
- V-set domain containing T cell activation inhibitor 1
- V-set domain containing T-cell activation inhibitor 1
- immune costimulatory protein B7-H4
- t cell costimulatory molecule B7x
- B7 family member, H4
- B7 superfamily member 1
- T cell costimulatory molecule B7x
- T-cell costimulatory molecule B7x